Hs.HRAS Q61L Citations (9)
Originally described in: RAS mutant collection V2.0Esposito unpublished
Articles Citing Hs.HRAS Q61L
| Articles |
|---|
| Inhibition of isoprenylcysteine carboxylmethyltransferase sensitizes common chemotherapies in cervical cancer via Ras-dependent pathway. Pan Q, Liu R, Banu H, Ma L, Li H. Biomed Pharmacother. 2018 Mar;99:169-175. doi: 10.1016/j.biopha.2018.01.048. Epub 2018 Jan 11. PubMed |
| Isoprenylcysteine carboxylmethyltransferase regulates ovarian cancer cell response to chemotherapy and Ras activation. Liu Q, Chen J, Fu B, Dai J, Zhao Y, Lai L. Biochem Biophys Res Commun. 2018 Jun 22;501(2):556-562. doi: 10.1016/j.bbrc.2018.05.038. Epub 2018 May 11. PubMed |
| Isoprenylcysteine carboxylmethyltransferase is associated with nasopharyngeal carcinoma chemoresistance and Ras activation. Zhu Y, Hu Q, Li H. Biochem Biophys Res Commun. 2019 Aug 27;516(3):784-789. doi: 10.1016/j.bbrc.2019.06.074. Epub 2019 Jun 26. PubMed |
| Prenylation-dependent Ras inhibition by pamidronate inhibits pediatric acute myeloid leukemia stem and differentiated cell growth and survival. Wang C, Liu X, He R, Li J, Pan R. Biochem Biophys Res Commun. 2019 Sep 24;517(3):439-444. doi: 10.1016/j.bbrc.2019.07.107. Epub 2019 Jul 31. PubMed |
| Cytotoxicity of amide-linked local anesthetics on melanoma cells via inhibition of Ras and RhoA signaling independent of sodium channel blockade. Zheng Q, Peng X, Zhang Y. BMC Anesthesiol. 2020 Feb 21;20(1):43. doi: 10.1186/s12871-020-00957-4. PubMed |
| Fentanyl inhibits acute myeloid leukemia differentiated cells and committed progenitors via opioid receptor-independent suppression of Ras and STAT5 pathways. Dai S, Zhang X, Zhang P, Zheng X, Pang Q. Fundam Clin Pharmacol. 2020 Jun 21. doi: 10.1111/fcp.12581. PubMed |
| Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma. Lu H, Zhou L, Zuo H, Le W, Hu J, Zhang T, Li M, Yuan Y. Cancer Chemother Pharmacol. 2021 Feb;87(2):217-228. doi: 10.1007/s00280-020-04199-6. Epub 2020 Nov 23. PubMed |
| Isoprenylcysteine carboxyl methyltransferase is critical for glioblastoma growth and survival by activating Ras/Raf/Mek/Erk. Wan W, Xiao W, Pan W, Chen L, Liu Z, Xu J. Cancer Chemother Pharmacol. 2022 Mar;89(3):401-411. doi: 10.1007/s00280-022-04401-x. Epub 2022 Feb 16. PubMed |
| Overcoming chemoresistance in glioblastoma by fluvastatin via prenylation-dependent inhibition of Ras signaling. Long C, Yuan L, Wei W, Li J. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221125934. doi: 10.1177/09603271221125934. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.